[1]
Parisi, S. et al. 2014. Efficacy of bosentan in the treatment of Raynaud’s phenomenon in patients with systemic sclerosis never treated with prostanoids. Reumatismo. 65, 6 (Mar. 2014), 286–291. DOI:https://doi.org/10.4081/reumatismo.2013.691.